Ads

You May Also Like

Aquinox to Present at LEERINK Partners 5th Annual Global Healthcare Conference

VANCOUVER, British Columbia, Jan. 28, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), ...

Immune Design Reports Second Quarter 2018 Financial Results and Provides Corporate Update

G100 advancing to late-stage development following FDA feedbackConference call at 1:30 pm Pacific todaySEATTLE, ...

Altimmune Restructures Financing Agreement with Majority of the Remaining Series B Investors

GAITHERSBURG, Md., July 12, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics ...